STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で20.35%の成長率を示しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 474.27です。
高配当
同社は高配当銘柄であり、最新の配当性向は36.04%です。
安定配当
同社は過去5年間にわたり継続的に配当を実施しており、最新の配当性向は36.04%です。
適正水準
同社の最新のPEは37.93で、過去3年間の水準と比較して適正圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は92.92M株で、前四半期比で2.55%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を12.12M株保有しています。